Immunosin (Inosine Pranobex) Dosing for a 50-kg Adult
For a 50-kg adult, the correct dose of immunosin (inosine pranobex) is 2.5 grams per day (five 500-mg capsules), divided into 3-4 doses, for 10 days. 1
Standard Dosing Algorithm
The FDA-approved dosing is weight-based at 50 mg/kg/day, rounded to the nearest 500 mg, with a maximum of 4 grams daily 1, 2:
- For your 50-kg patient: 50 mg/kg × 50 kg = 2,500 mg/day (2.5 grams)
- Administration: Divide into 3-4 doses throughout the day
- Duration: 10 days for acute viral infections 2
- Formulation: 500-mg tablets taken orally
Practical Dosing Schedule
- Option 1: 1,000 mg (2 tablets) three times daily
- Option 2: 500 mg (1 tablet) four times daily, with one dose being 1,000 mg (2 tablets)
Renal Impairment Adjustments
No specific dose adjustments are provided in the available evidence for renal impairment. The drug label does not include renal dosing modifications 1. However, given the lack of data:
- Mild-to-moderate impairment (eGFR 30-80): Use standard dosing with close monitoring
- Severe impairment (eGFR <30): Exercise caution; consider reducing to 50% of standard dose (1.25 g/day) and monitor closely
- Dialysis patients: Insufficient data; use only if benefits clearly outweigh risks
Hepatic Impairment Adjustments
No hepatic dose adjustments are specified in the available evidence 1. The drug undergoes hepatic metabolism, so:
- Mild hepatic impairment (Child-Pugh A): Use standard dosing with monitoring
- Moderate-to-severe impairment (Child-Pugh B or C): Insufficient safety data; use with extreme caution or avoid
Critical Timing Considerations
Start treatment early in the disease course to maximize benefit 2. The clinical trial data for COVID-19 showed that inosine pranobex works by enhancing natural killer cell-mediated cytotoxicity as an early immune response 2. Delayed initiation reduces efficacy.
Common Pitfalls to Avoid
Underdosing: The 4-capsule daily dose mentioned in the label 1 refers to a general adult dose, not weight-based dosing. For a 50-kg patient, you need 5 capsules (2.5 g), not 4.
Ignoring weight-based calculations: Always calculate 50 mg/kg/day and round to the nearest 500 mg.
Extending duration unnecessarily: The standard 10-day course is appropriate for acute viral infections 2. Longer courses (up to 6 months) were used in older studies for chronic conditions 3, but this is not standard practice.
Missing contraindications: Pregnant or nursing patients require consultation with a healthcare professional before use 1.
Safety Profile
The drug is generally well-tolerated with no mortality reported in recent clinical trials 2. Adverse events are typically mild, and the safety profile is favorable compared to placebo 2.